The Role of Novel Oral Anticoagulants and Antiplatelet Therapy after Percutaneous Coronary Intervention: Individualizing Therapy to Optimize Outcomes

The number of patients undergoing percutaneous coronary intervention (PCI) who mandate additional oral anticoagulant therapy has been increasing. Dual antiplatelet therapy (DAPT) is associated with reduced ischemic events including stent thrombosis, myocardial infarction and stroke following PCI. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Shlofmitz, Evan, Shlofmitz, Richard, Lee, Michael S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675700/
https://www.ncbi.nlm.nih.gov/pubmed/31347321
http://dx.doi.org/10.4070/kcj.2019.0185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675700/
https://www.ncbi.nlm.nih.gov/pubmed/31347321
http://dx.doi.org/10.4070/kcj.2019.0185

Ejemplares similares